Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug 17:13:941586.
doi: 10.3389/fimmu.2022.941586. eCollection 2022.

Placental damage in pregnancies with systemic lupus erythematosus: A narrative review

Affiliations
Review

Placental damage in pregnancies with systemic lupus erythematosus: A narrative review

Aleida Susana Castellanos Gutierrez et al. Front Immunol. .

Abstract

Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease of unknown cause, which mainly affects women of childbearing age, especially between 15 and 55 years of age. During pregnancy, SLE is associated with a high risk of perinatal morbidity and mortality. Among the most frequent complications are spontaneous abortion, fetal death, prematurity, intrauterine Fetal growth restriction (FGR), and preeclampsia (PE). The pathophysiology underlying obstetric mortality and morbidity in SLE is still under investigation, but several studies in recent years have suggested that placental dysfunction may play a crucial role. Understanding this association will contribute to developing therapeutic options and improving patient management thus reducing the occurrence of adverse pregnancy outcomes in this group of women. In this review, we will focus on the relationship between SLE and placental insufficiency leading to adverse pregnancy outcomes.

Keywords: antiphospholipid antibodies; complement system; cytokines; histopathology; neutrophil extracellular traps; placenta; systemic lupus erythematosus.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Histopathologic changes observed in placentas of patients with SLE. (A) Extensive infarction. (B) Abruptio placenta. (C) Decidual vasculopathy. (D) Decidua thrombi.
Figure 2
Figure 2
Complement alterations of patients with systemic lupus erythematosus (SLE).

Similar articles

Cited by

References

    1. Hayslett JP. The effect of systemic lupus erythematosus on pregnancy and pregnancy outcome. Am J Reprod Immunol (1992) 28(3-4):199–204. doi: 10.1111/j.1600-0897.1992.tb00791.x - DOI - PubMed
    1. Marder W, Knight JS, Kaplan MJ, Somers EC, Zhang X, O’Dell AA, et al. . Placental histology and neutrophil extracellular traps in lupus and pre-eclampsia pregnancies. Lupus Sci Med (2016) 3(1):e000134. doi: 10.1136/lupus-2015-000134 - DOI - PMC - PubMed
    1. Kiss E, Bhattoa HP, Bettembuk P, Balogh A, Szegedi G. Pregnancy in women with systemic lupus erythematosus. Eur J Obstet Gynecol Reprod Biol (2002) 101(2):129–34. doi: 10.1016/S0301-2115(01)00525-5 - DOI - PubMed
    1. Ostensen M, Clowse M. Pathogenesis of pregnancy complications in systemic lupus erythematosus. Curr Opin Rheumatol (2013) 25(5):591–6. doi: 10.1097/BOR.0b013e328363ebf7 - DOI - PubMed
    1. Clowse MEB, Chakravarty E, Costenbader KH, Chambers C, Michaud K. Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res (2012) 64(5):668–74. doi: 10.1002/acr.21593 - DOI - PubMed

Publication types